TNF and bladder transitional cell carcinoma: Moreover, TNF-based risk score could accurately stratify BLCA patients into basal and luminal subtypes, which reclarified the potential role for predicting the immune phenotypes and immunotherapy response from the aspect of molecular subtypes.